David A. Siegel Twist Bioscience Corp Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 215,600 shares of TWST stock, worth $8.99 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
215,600
Previous 280,500
23.14%
Holding current value
$8.99 Million
Previous $12.7 Million
20.94%
% of portfolio
0.02%
Previous 0.03%
Shares
21 transactions
Others Institutions Holding TWST
# of Institutions
270Shares Held
67.2MCall Options Held
118KPut Options Held
40.2K-
Artisan Partners Limited Partnership Milwaukee, WI5.89MShares$246 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$242 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.6MShares$233 Million2.28% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$226 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$149 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.35B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...